Research is at the center of all we do here at the SRF to find a cure for scleroderma. This is why, in 2018, we launched CONQUER (COllaborative, National QUality...
Read More
It’s the rarest day of the year: #RareDiseaseDay! You all have blown us away with how you’ve engaged with raising awareness of rare diseases like #scleroderma. There are 6,000+ rare diseases,…
In this month's eNews, read about Dr. Howard Chang's groundbreaking new study exploring why women are more likely to develop autoimmune conditions. We're also featuring patient stories, including Dee's experiences...
Read More
Nearly 90% of those with scleroderma have Raynaud’s symptoms. This is why Raynaud’s can be a “red flag” that helps lead to diagnosis and treatment of scleroderma. And for Aneila, dx…
February is #RaynaudsAwarenessMonth, so let’s discuss the relationship between #RaynaudsPhenomenon and #scleroderma. Raynaud’s phenomenon is a common condition, and most people with Raynaud’s will not develop scleroderma. The majority of people living with Raynaud’s…
Research News Alert: SRF-funded researcher Dr. Howard Chang and his collaborators have made a breakthrough discovery that sheds light on why women are more likely than men to develop certain...
Read More
February is Rare Disease Awareness Month. It's an opportunity for us to come together and raise awareness about what it means to live with a rare disease like #scleroderma. To...
Read More
Give a big round of applause to the SRF Cure Crew—in 2023 alone, they raised more than $158,000 for research! The Cure Crew is a grassroots group of volunteers that...
Read More
For our first edition of 2024, we're putting the new in eNews! In this edition, we introduced our first ever Chief Medical Officer, Dr. Greg Gordon, gave updates on novel...
Read More
Dr. Gordon will have oversight over the SRF’s global clinical trial program CONQUEST and will contribute to the research program across the SRF portfolio San Francisco, CA (January 25, 2024)…
